𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic markers in triple-negative breast cancer

✍ Scribed by Emad A. Rakha; Maysa E. El-Sayed; Andrew R. Green; Andrew H. S. Lee; John F. Robertson; Ian O. Ellis

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
157 KB
Volume
109
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic markers in node-negative brea
Prognostic markers in node-negative breast cancer: A prospective study
✍ Kute, T. E. ;Russell, G. B. ;Zbieranski, N. ;Long, R. ;Johnston, S. ;Williams, H πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 126 KB

## Abstract ## Background Despite years of research, it is still unclear which women with node‐negative (N–) breast cancer will need adjuvant chemotherapy and which women are being treated unnecessarily. Our goal was to determine which factors best predicted disease free survival (DFS) or cancer‐s

How basal are triple-negative breast can
How basal are triple-negative breast cancers?
✍ FranΓ§ois Bertucci; Pascal Finetti; Nathalie Cervera; Benjamin Esterni; Fabienne πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 99 KB

## Abstract The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression pattern of an intrinsic ∼500‐gene set. It is the most homogeneous subtype in transcriptional terms, and one of the most aggressive in prognostic terms. Clinical trials testing new systemic therapeutic st